ECO Animal Health Group plc

EAH

GB0032036807

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:00 17/05/2024 BST			5-day change	1st Jan Change
118 ^GBX	0.00%		0.00%	+8.76%

05-08	TRADING UPDATES: ECO hails vaccine results; Plant Health sales down	AN
04-25	EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling	AN

ECO Animal Health Group plc Provides Earnings Guidance for the Full Year Ended 31 March 2020

June 10, 2020 at 07:00 am

ECO Animal Health Group plc provided earnings guidance for the full year ended 31 March 2020. For the full year of fiscal 2020, Group revenue expected to be significantly ahead of market expectations.

Latest news about ECO Animal Health Group plc

TRADING UPDATES: ECO hails vaccine results; Plant Health sales down	05-08	AN
EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling	04-25	AN
Eco Animal Health Group plc Provides Earnings Guidance for the Year 2024	04-25	CI
ECO Animal Health streamlines product portfolio with disposal	04-04	AN
Eco Animal Health Strikes EUR1.3 Million Deal to Sell Equine Parasites Treatment	04-04	MT
Acme Drugs - S.R.L. acquired ECOmectin® Horsepaste from ECO Animal Health Group plc for £1.1 million.	04-03	CI
EARNINGS AND TRADING: Getech confident; Aukett Swanke makes buy	03-21	AN
ECO Animal Health Group plc Provides Revenue Guidance for the Full Year Ending 31 March 2024	03-21	CI
Eco Animal Health Sees FY Revenue In-Line With Market Expectations	03-21	RE
ECO Animal Health Group plc Appoints Joachim Hasenmaier as Non-Executive Director	02-12	CI
ECO Animal Health gets Ecovaxxin vaccines trademark approval in EU	02-06	AN
ECO Animal Health Group plc Announces the ECOVAXXIN Family in the EU	02-06	CI
Eco Animal Health sells properties for GBP1.1 million total	01-08	AN
Eco Animal Health Group Completes Sale of Former UK Office	01-08	MT
ECO Animal Health swings to first half loss but revenue rises	11-27	AN
ECO Animal Health swings to second half loss but revenue rises	11-27	AN
Earnings Flash (EAH.L) ECO ANIMAL HEALTH GROUP Posts Fiscal H1 Revenue GBP38M	11-27	MT
ECO Animal Health Group plc Reports Earnings Results for the Half Year Ended September 30, 2023	11-27	CI
Shore Capital Begins Eco Animal Health Coverage at Buy Rating	11-17	MT
Shore cuts Sage; Barclays raises NatWest	11-17	AN
ECO Animal Health up on new US and Canada label claim for Aivlosin	24/10/23	AN
ECO Animal Health Gains New Label Indication for Pig Antibiotic in US, Canada	24/10/23	MT
ECO Animal Health Group plc Announces New USA and Canada Label Claim for Aivlosin®	24/10/23	CI
FTSE 100 Closes Up 0.2% Lifted by Oil Stocks	10/07/23	DJ
UK Long-Dated Gilt-Yields Rising Fast, Inverted Gilt Yield Curve Flattens	10/07/23	DJ

Chart ECO Animal Health Group plc

Duration

Period

More charts

Company Profile

ECO Animal Health Group plc is a United Kingdom-based animal health biotechnology company. The Company is engaged in the manufacturing and supplying of animal health products globally. The Company is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. It provides quality products for swine and poultry, primarily anti-infectives. The Companyâs segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. The Company research, develops and commercializes products for livestock. The Companyâs lead product, Aivlosin, is an antimicrobial which is used under veterinary prescription for the treatment of economically important respiratory and gastrointestinal diseases in pigs and poultry. The Company is also engaged in researching and developing new solutions to enhance the lives of pigs and poultry.

Sector

Pharmaceuticals

Calendar

30/06/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for ECO Animal Health Group plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.18 GBP

Average target price

1.851 GBP

Spread / Average Target

+56.89%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
ECO ANIMAL HEALTH GROUP PLC	+8.76%	102M
ZOETIS INC.	-11.83%	79.42B
BLUESTAR ADISSEO COMPANY	+28.00%	3.8B
VIRBAC	-1.39%	3.23B
VIMIAN GROUP AB	+21.28%	1.75B
JINYU BIO-TECHNOLOGY CO., LTD.	-3.25%	1.61B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-18.63%	1.36B
VETOQUINOL SA	-1.17%	1.3B
WUHAN KEQIAN BIOLOGY CO.,LTD	-6.77%	1.22B
PULIKE BIOLOGICAL ENGINEERING, INC.	+2.34%	1.11B

Veterinary Drugs